Your Patient Can't Find Nisoldipine XR — Here's How to Help

You've prescribed Nisoldipine XR for a patient's hypertension, and they're calling back because their pharmacy can't fill it. Or maybe you're seeing this pattern repeatedly — patients reporting that Nisoldipine XR is out of stock, on backorder, or simply not carried by their pharmacy.

This situation has become increasingly common. As a provider, you're in a unique position to help patients navigate these challenges before they result in missed doses and uncontrolled blood pressure.

Current Availability of Nisoldipine XR

Nisoldipine XR (formerly brand Sular) faces a combination of factors that limit its availability:

• Brand discontinued: Sular was taken off the market for commercial reasons, not safety concerns (per FDA determination, 2014). No brand-name fallback exists.
• Few generic manufacturers: Production is limited to a small number of companies (primarily Emcure Pharmaceuticals USA). This creates a fragile supply chain vulnerable to disruption.
• Low pharmacy stocking: With relatively few prescriptions written nationally compared to Amlodipine or Nifedipine ER, most pharmacies — especially chains — do not keep Nisoldipine XR in routine inventory.
• Inconsistent wholesaler supply: Even when manufacturers are producing Nisoldipine XR, distribution through wholesalers to individual pharmacies can be unpredictable.

The result: patients face a real-world availability problem even though the drug is technically in production.

Why Patients Can't Find It on Their Own

Patients encounter several barriers when trying to locate Nisoldipine XR:

• Limited pharmacy knowledge: Most patients don't know to try independent pharmacies, contact wholesalers, or use pharmacy locator tools
• Frustration and resignation: After being told "we don't carry that" by two or three pharmacies, many patients give up rather than continuing to search
• Reluctance to contact their doctor: Some patients assume their provider can't help with a pharmacy supply issue, so they don't call until they've already missed doses
• Fear of changing medications: Patients who are stable on Nisoldipine XR may resist switching, even when alternatives are clinically appropriate

5 Steps Providers Can Take to Help

Step 1: Use a Pharmacy Locator Tool During the Visit

Before your patient leaves the office, use Medfinder for Providers to search for pharmacies near the patient's home or workplace that currently have Nisoldipine XR in stock. This takes less than a minute and can save the patient hours of calling around.

If a specific pharmacy shows availability, you can send the prescription directly there — eliminating the most common point of failure.

Step 2: Prescribe 90-Day Supplies When Possible

If your patient has insurance that covers 90-day fills (including many mail-order pharmacy benefits), prescribe accordingly. This reduces the number of times per year the patient needs to locate Nisoldipine XR from 12 to 4, significantly decreasing the chance of hitting a supply gap.

Step 3: Document an Alternative in the Chart

For every patient on Nisoldipine XR, document a preferred alternative medication and dose in the chart. This allows covering providers or on-call staff to quickly prescribe a bridge supply if the patient calls in unable to find their medication. Suggested alternatives include:

• Amlodipine: 2.5-10 mg daily (most widely available; $4-$10/month generic)
• Nifedipine ER: 30-90 mg daily (closest pharmacological match; $8-$20/month generic)
• Felodipine: 2.5-10 mg daily (similar vasoselectivity; generic available)

Step 4: Educate the Patient Proactively

At the prescribing visit, set expectations:

• "Nisoldipine XR can sometimes be hard to find at pharmacies. If your pharmacy doesn't have it, here's what to do..."
• Recommend they try independent pharmacies if their chain pharmacy can't fill the prescription
• Provide them with the Medfinder website so they can search for availability themselves
• Emphasize that they should never stop taking the medication abruptly — they should call your office if they can't get a refill

Step 5: Consider Whether Nisoldipine XR Is the Right Long-Term Choice

For new prescriptions, consider starting with a more readily available CCB unless there is a specific clinical reason to choose Nisoldipine. For existing patients, if supply problems are recurring, a proactive transition to a more available alternative may be in the patient's best interest — both for adherence and cost reasons.

Therapeutic Alternatives at a Glance

When transitioning from Nisoldipine XR, individual titration is recommended due to pharmacokinetic differences between agents. The following provides a general framework:

• Amlodipine (Norvasc): First-line CCB per ACC/AHA. Once daily. Long half-life (30-50 hours) provides stable control. Fewer food interactions. Universal availability. Cost: $4-$10/month.
• Nifedipine ER (Procardia XL, Adalat CC): Closest pharmacological match to Nisoldipine within the dihydropyridine class. Once daily extended-release. Well-studied for hypertension and angina. Cost: $8-$20/month.
• Felodipine (Plendil): Similar vasoselectivity to Nisoldipine. Once daily. Also has grapefruit interaction (counsel accordingly). Cost: $15-$40/month.

For patients who need to move away from the dihydropyridine class entirely (e.g., due to intolerable edema), Diltiazem ER or Verapamil ER are options, though they carry different side effect profiles and drug interaction considerations.

Workflow Tips for Your Practice

Integrating Nisoldipine XR supply awareness into your workflow doesn't have to be complicated:

• Flag Nisoldipine XR in your EHR: Add an alert or reminder to charts of patients on Nisoldipine XR noting the potential for supply issues and the documented alternative
• Train front desk and nursing staff: Ensure they know how to handle calls from patients who can't fill Nisoldipine XR — including checking Medfinder and escalating to the prescriber for an alternative if needed
• Batch-check at refill time: When processing refill requests for Nisoldipine XR, verify with the receiving pharmacy that they have it in stock before sending the prescription
• Include in transition-of-care notes: When referring patients to specialists or discharging from hospital, note the supply challenges with Nisoldipine XR so the receiving provider is aware

Final Thoughts

Nisoldipine XR remains a clinically effective antihypertensive, but the ongoing availability challenges make it a medication that requires extra provider attention. By taking proactive steps — using pharmacy locator tools, documenting alternatives, and educating patients — you can significantly reduce the risk of treatment gaps for your patients.

Medfinder for Providers is a free tool designed to help providers and their staff quickly locate pharmacies with hard-to-find medications in stock. Bookmark it for use during patient encounters.

For the patient-facing perspective on this issue, see our Nisoldipine XR shortage update for patients.